Valneva’s chikungunya virus vaccine granted breakthrough designation
Currently, no preventative vaccines or effective treatments are available for the chikungunya virus
Read More
Tag: chikungunya vaccine
- Johnson & Johnson reports phase 2 data showing nipocalimab reduced SLE disease activity
- European approval enables measles protection with CSL’s immunoglobulin Privigen
- JJP Biologics reports positive interim phase 1b data for nebaprubart
- Immunotherapy boost can spare more bladder cancer patients major surgery
- Deep Science Ventures and MDC partner to accelerate brain treatments
